| 1 |
32369955 | Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy. | 2020 May 1 |
2 |
| 2 |
32903307 | The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARĪ³/STAT1 Signaling Pathway. | 2020 |
2 |
| 3 |
29459481 | Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. | 2018 Apr |
2 |
| 4 |
29138698 | Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus. | 2017 |
1 |
| 5 |
24309146 | Discovery of soluble epoxide hydrolase inhibitors from natural products. | 2014 Feb |
1 |
| 6 |
25162465 | Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. | 2014 Oct 15 |
1 |
| 7 |
25406731 | Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer. | 2014 Nov 18 |
1 |
| 8 |
23362272 | Soluble epoxide hydrolase dimerization is required for hydrolase activity. | 2013 Mar 15 |
2 |
| 9 |
24148690 | The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. | 2013 Oct 23 |
2 |
| 10 |
20008276 | Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. | 2010 Feb |
2 |